Cytokine-mediated inflammatory signaling pathway

Cytokine-mediated inflammatory signaling is a fundamental biological process involving the release of signaling proteins that coordinate the body's immune response to injury or infection. Upon binding to their respective transmembrane receptors, cytokines initiate intracellular cascades—most notably the JAK/STAT and NF-kappaB pathways—that lead to the transcription of pro-inflammatory genes (Source: NIH, National Institute of Allergy and Infectious Diseases). While this signaling is vital for pathogen clearance, its chronic or overactive state is a primary driver of autoimmune and autoinflammatory diseases such as rheumatoid arthritis and Crohn's disease (Source: PubMed, PMID: 28190774). Modern pharmacology targets this pathway through biologics that sequester cytokines like TNF-alpha or IL-6, or through small-molecule inhibitors that block the enzymatic activity of downstream kinases (Source: StatPearls, Cytokine Inhibitors). Monitoring this signaling often involves measuring systemic biomarkers like C-reactive protein or specific cytokine levels in the blood to assess disease activity and treatment response (Source: PubMed, PMID: 30272134). This signaling network represents a broad therapeutic area rather than a single molecular target, encompassing a wide array of receptors and enzymes (Source: Nature Reviews Drug Discovery, PMID: 24056917).

Other names

Pro-inflammatory cytokine signalingCytokine signaling cascadeInflammatory cytokine pathway

Neutralization of pro-inflammatory cytokines, competitive antagonism of cytokine receptors, or inhibition of downstream intracellular signaling transducers such as Janus kinases (JAKs).